Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM151A pseudogene 1 (FAM151AP1) is a processed pseudogene in humans. Pseudogenes like FAM151AP1 arise through duplication or retrotransposition of a parent gene—in this case, likely the FAM151A gene[5][7]. Processed pseudogenes are typically not transcribed or translated into functional proteins due to disruptive mutations and lack of regulatory elements[2]. Some pseudogenes can play regulatory roles by acting as decoys for microRNAs or generating noncoding RNAs affecting gene expression, but no specific biological function, disease relevance, or pharmacological targeting has been reported for FAM151AP1[5][2][6]. Information from large genomic resources classifies it as noncoding with no clear links to disease, protein production, or therapeutic application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM151A pseudogene 1 (FAM151AP1).